Ventas Inc(VTR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 160.34 | EPS (ttm) | 0.55 | Insider Own | 0.54% | Shs Outstand | 513.0M | Perf Week | 3.44% |
| Market Cap | 44.84B | Forward P/E | 92.3 | EPS next Y | 60.65% | Insider Trans | 0.05% | Shs Float | 510.2M | Perf Month | 0.96% |
| Enterprise Value | 58.16B | PEG | 2.8 | EPS next Q | 0.16 | Inst Own | 105.13% | Short Float | 3.23% | Perf Quarter | -10.92% |
| Income | 0.26B | P/S | 6.96 | EPS this Y | 9.18% | Inst Trans | 3.41% | Short Ratio | 4.62 | Perf Half Y | 3.21% |
| Sales | 6.44B | P/B | 3.06 | EPS next 5Y | 33.02% | ROA | 0.94% | Short Interest | 16.50M | Perf YTD | 12.97% |
| Book/sh | 28.56 | P/C | 200.35 | EPS past 3/5Y | - -14.17% | ROE | 2.01% | 52W High | -13.96% ($101.60) | Perf Year | 24.19% |
| Cash/sh | 0.44 | P/FCF | 31.11 | Sales past 3/5Y | 12.23% 8.99% | ROIC | 0.98% | 52W Low | 28.28% ($68.15) | Perf 3Y | 110.56% |
| Dividend Est. | $2.08 (2.38%) | EV/EBITDA | 24.65 | EPS Y/Y TTM | 26.45% | Gross Margin | 18.38% | Volatility(W/M) | 1.92% 2.12% | Perf 5Y | 63.77% |
| Dividend TTM | 2.04 | EV/Sales | 9.03 | Sales Y/Y TTM | 21.49% | Oper. Margin | 14.83% | ATR (14) | 1.78 | Perf 10Y | 31.05% |
| Dividend Ex-Date | 2026/9/30 | Quick Ratio | 0.71 | EPS Q/Q | -4.64% | Profit Margin | 4.08% | RSI (14) | 56.49 | Recom | 1.5 |
| Dividend Gr. 3/5Y | 2.17% -2.15% | Current Ratio | 0.71 | Sales Q/Q | 21.73% | SMA20 | 3.66% ($84.33) | Beta | 0.78 | Target Price | $100.81 |
| Payout | 353.33% | Debt/Eq | 0.89 | Earnings | 2026/10/27 | SMA50 | -0.45% ($87.82) | Rel Volume | 0.55 | Prev Close | $86.8 |
| Employees | 542 | LT Debt/Eq | 0.84 | EPS/Sales Surpr. | -1.62% 2.91% | SMA200 | 1.18% ($86.4) | Avg Volume(3M) | 3.57M | Price | $87.42 |
| IPO | 1989/9/19 | Option/Short | Yes/Yes | Trades | 19460 | Volume | 1,946,585 | Change | 0.71% |
🏥 This is a major U.S. healthcare REIT that operates senior housing, medical office buildings, and life science research facilities. Since its spin-off launch in 1998, it has managed an extensive healthcare real estate portfolio across North America and the United Kingdom, with a focus on senior housing, and is widely regarded as a key beneficiary of population aging trends.
Over the past 1 year, roughly in the middle
14% below its 1-year high.
Traded less than usual. That is 55% of its average volume.
Next earnings report: October 27
That is today.
VTR has weak earning power
After all costs, only $4.08 of every $100 in sales is left.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +9.2% this year.
Tap to view numbers
However, it looks expensive
For a company expected to earn $100 next year, you would pay $9,230. Peers typically go for $3,093. It is about in line with its own 3-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +63.8%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 2.38% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 105.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #2 of 17 in the industry
Based on market cap of $45B.
FAQ
What kind of company is VTR?
VTR belongs to the Real Estate sector and operates in the REIT - Healthcare Facilities industry.
What is the market cap of VTR?
The market cap of VTR is approximately $44.8B, ranking 345 within its sector.
Does VTR pay dividends?
VTR has a dividend yield of approximately 2.38%, with an annual dividend of $2.08.
What is the P/E ratio of VTR?
VTR has a P/E ratio of approximately 160.3x, which can be used to assess its valuation relative to the Real Estate sector average.
What is the 52-week high and low for VTR?
VTR has recorded a 52-week high of $101.60 and a low of $68.15.
